| AID in antibody diversification: there and back again Y Feng, N Seija, JM Di Noia, A Martin Trends in immunology 41 (7), 586-600, 2020 | 126 | 2020 |
| S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression D Prieto, N Sotelo, N Seija, S Sernbo, C Abreu, R Durán, M Gil, E Sicco, ... Blood, The Journal of the American Society of Hematology 130 (6), 777-788, 2017 | 94 | 2017 |
| FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation Y Feng, C Li, JA Stewart, P Barbulescu, N Seija Desivo, A Álvarez-Quilón, ... Nature 600 (7888), 324-328, 2021 | 32 | 2021 |
| Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia PE Morande, M Sivina, A Uriepero, N Seija, C Berca, P Fresia, AI Landoni, ... Blood, The Journal of the American Society of Hematology 133 (19), 2056-2068, 2019 | 19 | 2019 |
| AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms PE Morande, XJ Yan, J Sepulveda, N Seija, ME Marquez, N Sotelo, ... Blood, The Journal of the American Society of Hematology 138 (3), 246-258, 2021 | 13 | 2021 |
| LPL protein in chronic lymphocytic leukaemia have different origins in mutated and unmutated patients. Advances for a new prognostic marker in CLL D Prieto, N Seija, A Uriepero, T Souto‐Padron, C Oliver, V Irigoin, ... British journal of haematology 182 (4), 521-525, 2018 | 12 | 2018 |
| AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination S Tsukumo, PG Subramani, N Seija, M Tabata, Y Maekawa, Y Mori, ... Science Advances 8 (34), eabq0008, 2022 | 8 | 2022 |
| Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia D Risnik, A Colado, E Podaza, MB Almejún, EE Elías, RF Bezares, ... Cancer Immunology, Immunotherapy 69, 813-824, 2020 | 7 | 2020 |
| The Antigen Receptor as a Driver of B-Cell Lymphoma Development and Evolution J Sepulveda, N Seija, P Oppezzo, MA Navarrete Hematology- Latest Research and Clinical Advances, 2017 | 3 | 2017 |
| Analyzing the mutational landscape of two CLL mouse models overexpressing AID identifies proliferative fraction-associated tumor genes involved in leukemic development and … P Morande, J Yan, J Sepulveda, N Seija, M Crispo, N Rego, D Robbiani, ... LEUKEMIA & LYMPHOMA 61, 133-134, 2020 | 1 | 2020 |
| Implicancias de la enzima AID en la mutagénesis y evolución clonal durante la progresión de la Leucemia Linfoide Crónica N Seija Udelar. FC., 2018 | 1 | 2018 |
| B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1 Y Liang, HC Wang, N Seija, YH Lin, LT Tung, JM Di Noia, D Langlais, ... Frontiers in Immunology 15, 1353138, 2024 | | 2024 |
| DOT1L limits RNAPII promoter-proximal pause release thus enabling Activation Induced Deaminase activity genome-wide PG Subramani, N Seija, J Ridani, J Boulais, P Donnelly, M Provencher, ... | | 2023 |
| Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia P Morande, M Sivina, A Uriepero, N Seija, C Berca, P Fresia, AI Landoni, ... LEUKEMIA & LYMPHOMA 61, 130-132, 2020 | | 2020 |
| Desenmarañando la progresión de la LLC en pacientes no mutados:: relación entre la expresión funcional de la citidina deaminasa inducida por activación con la evolución de la … N Seija, J Sepulveda, D Prieto, P Morande, A Uriepero, M Navarrete, ... Revista Hematología 22 (2), 33-35, 2018 | | 2018 |
| Unraveling CLL progression in unmutated patients: linking functional AID expression with disease evolution P Oppezzo, N Seija, D Prieto, J Sepulveda, P Morande, A Uriepero, ... LEUKEMIA & LYMPHOMA 58, 207-208, 2017 | | 2017 |
| AID and LPL mRNA expression identify patients with different clinical outcomes within UM CLLs P Oppezzo, A Ines Landoni, V Irigoin, C Oliver, V Remedi, G Borelli, ... LEUKEMIA & LYMPHOMA 58, 202-203, 2017 | | 2017 |
| GIMAP5 protein is over expressed in CLL proliferative subsets and linked with cell death inhibition P Oppezzo, C Abreu, D Prieto, C Ortega, F Palacios, N Seija, G Greif, ... LEUKEMIA & LYMPHOMA 58, 98-99, 2017 | | 2017 |
| Proteomic characterization of CLL plasma exosomes during disease evolution identify S100-A9 protein as a key molecule in the activation of the canonical NF-kB pathway P Oppezzo, D Prieto, N Seija, N Sotelo, C Abreu, C Ortega, R Duran, ... LEUKEMIA & LYMPHOMA 58, 90-90, 2017 | | 2017 |
| Constitutive aid expression in CLL mouse model leads to disease progression, tumor proliferation and diminished survival P Morande, XJ Yan, N Sotelo, D Prieto, N Seija, M Crispo, N Chiorazzi, ... LEUKEMIA & LYMPHOMA 56, 74-74, 2015 | | 2015 |
